FindTrial
Sign In

An Open-label Controlled Trial to Compare the Prevalence of Radiocontrast Induced Nephropathy between Iohexol and Iomeprol after Coronary Angiography in Patients with Chronic Kidney Disease

An Open-label Controlled Trial to Compare the Prevalence of Radiocontrast Induced Nephropathy between Iohexol and Iomeprol after Coronary Angiography in Patients with Chronic Kidney Disease - Comparison of the Prevalence of Radiocontrast Induced Nephropathy between Iohexol and Iomeprol after Coronary Angiography in Chronic Kidney Disease Patients

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000000892
Enrollment
500
Registered
2007-12-01
Start date
2008-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiocontrast induced nephropathy in chronic kidney disease patients

Interventions

Injection of Iohexol for contrast medium during coronary angiography(control group) Injection of Iomeprol for contrast medium during coronary angiography

Sponsors

Department of Nephrology Izumisano Municipal Hospital Rinku General Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The eGFR is 60ml/min/1.73m2 or less

Exclusion criteria

Exclusion criteria: Contraindication of radiocontrast agent Congestive heart failure(NYHA III,IV) Acute coronary syndrome Malignancy

Design outcomes

Primary

MeasureTime frame
Change in serum creatinine, estimated GFR and serum Cystatin C during two weeks after coronary angiography—

Secondary

MeasureTime frame
Kidney function after one year—

Countries

Japan

Contacts

Public ContactTerumasa Hayashi

Izumisano Municipal Hospital Rinku General Medical Center Department of Nephrology

t-hayashi@rgmc.izumisano.osaka.jp072-469-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026